Home > Insider Trading > Filing (0001599901-25-000150)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1599901	Avidity Biosciences Inc.	RNA	Pharmaceutical Preparations (2834)	461336960

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1747528	George Steven Hughes	C/O Avidity Biosciences, Inc. 10578 Science Center Drive, Suite 125 San Diego CA 92121	Chief Medical Officer	No	Yes	No	No

Transaction Summary

Sold:	81,434 shares	Avg. Price: $42.74	Total Value: $3,480,269.29
Number of Shares After Transactions:	38,867 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-08-06	11,283	$15.96	84,133	No	4	M	Direct
Common Stock	Disposition	2025-08-06	11,283	$42.74	72,850	No	4	S	Direct
Common Stock	Acquisiton	2025-08-06	12,334	$6.57	85,184	No	4	M	Direct
Common Stock	Disposition	2025-08-06	12,334	$42.74	72,850	No	4	S	Direct
Common Stock	Acquisiton	2025-08-06	6,167	$22.47	79,017	No	4	M	Direct
Common Stock	Disposition	2025-08-06	6,167	$42.74	72,850	No	4	S	Direct
Common Stock	Acquisiton	2025-08-06	17,667	$10.16	90,517	No	4	M	Direct
Common Stock	Disposition	2025-08-06	17,667	$42.74	72,850	No	4	S	Direct
Common Stock	Disposition	2025-08-06	33,983	$42.74	38,867	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2025-08-06	11,283	$0.00	11,283	$15.96
Common Stock	Stock Option (Right to Buy)	Disposition	2025-08-06	12,334	$0.00	12,334	$6.57
Common Stock	Stock Option (Right to Buy)	Disposition	2025-08-06	6,167	$0.00	6,167	$22.47
Common Stock	Stock Option (Right to Buy)	Disposition	2025-08-06	17,667	$0.00	17,667	$10.16

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
73,342	2032-02-13	No	4	M	Direct
52,417	2033-09-10	No	4	M	Direct
74,000	2033-01-19	No	4	M	Direct
75,083	2034-01-19	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.
This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.15 to $46.44. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This option was granted on February 14, 2022 and vests in equal installments of 5,652 shares on each monthly anniversary of such grant date, until it is fully vested and exercisable on February 14, 2026.
This option was granted on September 11, 2023 and vests in equal installments of 1,542 shares on each monthly anniversary of such grant date, until it is fully vested and exercisable on September 11, 2027.
This option was granted on January 20, 2023 and vests in equal installments of 3,083 shares on each monthly anniversary of such grant date, until it is fully vested and exercisable on January 20, 2027.
This option was granted on January 20, 2024 and vests in equal installments of 2,208 shares on each monthly anniversary of such grant date, until it is fully vested and exercisable on January 20, 2028.